MYGN - MYRIAD GENETICS INC
IEX Last Trade
13.52
0.050 0.370%
Share volume: 12,232
Last Updated: Fri 27 Dec 2024 08:30:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$13.47
0.05
0.37%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-02 | 2023-03-01 | 2023-05-04 | 2023-08-04 | 2023-11-07 | 2024-02-28 | 2024-05-08 | |
| Cash flow financing | 2.500 M | -3.600 M | -2.100 M | 4.900 M | 28.600 M | -2.500 M | 121.900 M | -8.800 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -50.300 M | -1.800 M | -7.700 M | -33.200 M | -900.000 K | -22.100 M | -54.700 M | -18.600 M | |
| Net income | -14.100 M | -35.100 M | -42.300 M | -54.700 M | -116.100 M | -61.300 M | -31.200 M | -26.000 M | |
| Depreciation | 12.900 M | 13.100 M | 13.700 M | 19.400 M | 13.300 M | 14.100 M | 15.100 M | 15.700 M | |
| Changes in inventories | 15.400 M | 19.600 M | 20.100 M | 21.800 M | 22.500 M | 25.100 M | 22.000 M | 24.600 M | |
| Changes in receivables | 109.800 M | 102.200 M | 101.600 M | 119.100 M | 111.700 M | 115.200 M | 114.300 M | 118.100 M | |
| Investing Cashflow | -12.000 M | 11.400 M | -35.600 M | 34.600 M | 11.800 M | -2.500 M | -12.000 M | -7.100 M | |
| Net Borrowings | -241.900 M | -230.500 M | -152.900 M | -120.700 M | -121.700 M | -86.600 M | -138.800 M | -108.900 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -6.700 M | -17.700 M | -14.600 M | -23.500 M | -18.800 M | -17.500 M | -3.400 M | -8.600 M | |
| Cash Change | 205.100 M | 193.200 M | 114.900 M | 78.700 M | 121.600 M | 86.300 M | 140.900 M | 104.300 M |